132 related articles for article (PubMed ID: 29415357)
1. High urinary interleukin-8 levels is associated with poor prognosis in idiopathic membranous nephropathy.
Chen J; Fu X; Sun Y; Zhang S; Xie H; Lin H
Intern Med J; 2018 Feb; 48(2):207-209. PubMed ID: 29415357
[TBL] [Abstract][Full Text] [Related]
2. Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy.
Chen X; Chen Y; Shi K; Lv Y; Tong H; Zhao G; Chen C; Chen B; Li D; Lu Z
Sci Rep; 2017 Sep; 7(1):11468. PubMed ID: 28904360
[TBL] [Abstract][Full Text] [Related]
3. Urinary Matrix Metalloproteinase-9 and Nephrin in Idiopathic Membranous Nephropathy: A Cross-Sectional Study.
Gilbert A; Changjuan A; Guixue C; Jianhua L; Xiaosong Q
Dis Markers; 2021; 2021():1620545. PubMed ID: 34707724
[TBL] [Abstract][Full Text] [Related]
4. Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.
Wang M; Xie R; Jia X; Liu R
Med Princ Pract; 2017; 26(4):375-380. PubMed ID: 28633145
[TBL] [Abstract][Full Text] [Related]
5. Level of interleukin-35 in patients with idiopathic membranous nephropathy and its predictive value for remission time.
Zhang N; Dai H; Dong X; Liu W; Jiang H; Zhao Q; Gao Y; Feng Z; Dong Z; Hu Y; Huang G; Rui H; Liu B
Front Immunol; 2022; 13():926368. PubMed ID: 35983038
[TBL] [Abstract][Full Text] [Related]
6. The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy.
Tang Z; Wang Y; Tao L; Guo Y; Zheng Y; Zheng D
BMC Nephrol; 2018 Dec; 19(1):357. PubMed ID: 30541470
[TBL] [Abstract][Full Text] [Related]
7. Detection and clinical significance of glomerular M-type phospholipase A
Liu H; Luo W; Gong S; Ding X
Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
[TBL] [Abstract][Full Text] [Related]
8. Response to immunosuppressive therapy in PLA
Wang J; Xie Q; Sun Z; Xu N; Li Y; Wang L; Liu S; Xue J; Hao CM
BMC Nephrol; 2017 Jul; 18(1):227. PubMed ID: 28693446
[TBL] [Abstract][Full Text] [Related]
9. Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.
Maas RJ; van den Brand JA; Waanders F; Meijer E; Goor van H; Peters HP; Hofstra JM; Wetzels JF
Ann Clin Biochem; 2016 Jan; 53(Pt 1):51-7. PubMed ID: 25762211
[TBL] [Abstract][Full Text] [Related]
10. Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy.
Zhang W; Ren Y; Li J
Ren Fail; 2019 Nov; 41(1):704-717. PubMed ID: 31352863
[No Abstract] [Full Text] [Related]
11. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
12. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
[TBL] [Abstract][Full Text] [Related]
14. Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy.
Xu NX; Xie QH; Sun ZX; Wang J; Li Y; Wang L; Liu SJ; Xue J; Hao CM
Chin Med J (Engl); 2017 Apr; 130(8):892-898. PubMed ID: 28397717
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study.
Branten AJ; du Buf-Vereijken PW; Klasen IS; Bosch FH; Feith GW; Hollander DA; Wetzels JF
J Am Soc Nephrol; 2005 Jan; 16(1):169-74. PubMed ID: 15563570
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and prognosis of idiopathic membranous nephropathy with thyroid dysfunction.
Wang P; Wang S; Huang B; Liu Y; Liu Y; Chen H; Zhang J
Front Endocrinol (Lausanne); 2023; 14():1133521. PubMed ID: 37008916
[TBL] [Abstract][Full Text] [Related]
17. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[TBL] [Abstract][Full Text] [Related]
18. Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy.
Chen X; Chen Y; Ding X; Zhou Y; Lv Y; Li D; Chen B; Chen T; Chen C
Ren Fail; 2019 Nov; 41(1):363-369. PubMed ID: 31057017
[TBL] [Abstract][Full Text] [Related]
19. Urine albumin-to-creatinine ratio diurnal variation rate predicts outcomes in idiopathic membranous nephropathy.
Chen X; Zhang Y; Yan L; Xie Y; Li S; Zhuang Y; Wang L
Clin Exp Nephrol; 2024 May; 28(5):409-420. PubMed ID: 38240880
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study.
Liu S; Li X; Li H; Liang Q; Chen J; Chen J
BMC Nephrol; 2015 Dec; 16():200. PubMed ID: 26637482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]